Back

Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pericarditis Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Moda

University of Milan, Milan (Italy)

7 More presentations in this session

Presentation thumbnail
Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry
Doctor P. Cremer (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Pushing boundaries, not the heart: a comparative look at pericarditis recurrence in athletes
Doctor E. Angelu (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Unveiling hidden myocardial dysfunction in acute pericarditis: the prognostic power of GLS
Doctor A. Andreis (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years
Doctor D. Lotan (New York, US)
Abstract Slides Video
Presentation thumbnail
Recurrent pericarditis: is Anakinra the only solution? Diagnostic and therapeutical insights from long-term follow-up of a large monocentric cohort
Doctor A. Giordani (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pericarditis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Recurrent pericarditis: is Anakinra the only solution? Diagnostic and therapeutical insights from long-term follow-up of a large monocentric cohort
thumbnail
Congress Presentation
Breaking therapeutic boundaries: high-dose IL-1 inhibitors in refractory recurrent pericarditis
thumbnail
Congress Session
Cases of cardiovascular disease in pregnancy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources